On the basis of these findings, we hypothesized that memory decline associated with aging was accelerated in APP/PS1 mice through enhanced GABAA receptor-mediated inhibition resulting from the effects of gene product(s) of early-onset AD such as Aß. This evidence concerns the gene APP and Alzheimer disease.